The company’s JUNIPER study is a Phase 2, randomized, double-blind, placebo-controlled, parallel group, dose-ranging, multi-center trial to evaluate the efficacy and safety of DaxibotulinumtoxinA for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback